-
Product Insights
Bone Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Bone Cancer Clinical Trial Report Overview A total of 1620 bone cancer clinical trials were conducted as of August 2024. The bone cancer clinical trial report provides a comprehensive understanding of the bone cancer clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions ·      North America ·      ...
-
Sector Analysis
Renal Cell Carcinoma (RCC) Epidemiology Analysis and Forecast to 2033
Renal Cell Carcinoma (RCC) Report Overview In the 8MM, there were 199,400 diagnosed incident cases of RCC in 2023. The diagnosed incident cases of RCC will register an AGR of more than 1% during 2023-2033. Renal cell carcinoma (RCC) is a disease in which cancer cells are found in the lining of kidney tubules. Renal Cell Carcinoma (RCC) Market Outlook, 2023-2033 (Diagnosed Incident Cases) Buy the Full Report for More Insights into the Renal Cell Carcinoma (RCC) Market Forecast Download...
-
Sector Analysis
Chondrosarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in Chondrosarcoma therapeutics. • In 2024, more than 13,000 diagnosed incident cases of CS are anticipated in the 16 countries covered in GlobalData’s epidemiology forecast for CS. • Currently, no approved disease-modifying therapy is available globally in the market space for CS. • R&D activities for CS are moderate with 29 molecules in the pipeline, out of which Phase III holds only one drug, whereas Phase II...
-
Sector Analysis
Soft Tissue Sarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Soft Tissue Sarcoma (STS) Marketed and Pipeline Drugs Report Overview Soft tissue sarcoma (STS) encompasses more than 50 types of cancer that develop in the body's soft tissues, which include muscles, fat, and nerves. These tumors primarily occur in areas like the arms, legs, chest, or abdomen. Soft tissue sarcomas exhibit diverse subtypes, each displaying unique traits and behaviors. They can differ in terms of aggressiveness, rate of growth, and propensity to metastasize to distant organs. In 2024, 368,024 diagnosed...
-
Product Insights
Marginal Zone B-cell Lymphoma - Drugs In Development, 2024
Empower your strategies with our Marginal Zone B-cell Lymphoma – Drugs In Development, 2024 report and make more profitable business decisions. Marginal zone B-cell lymphoma is a slow-growing, non-Hodgkin lymphoma that originates from B cells at the margins of lymphoid tissues. It's divided into three subtypes: extranodal, nodal, and splenic, each with distinct features. Extranodal marginal zone lymphoma primarily affects organs outside the lymph nodes, such as the stomach (gastric MALT lymphoma) or the eye (ocular MALT lymphoma). Symptoms may include...
-
Product Insights
Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Drugs In Development, 2024
Empower your strategies with our Transitional Cell Carcinoma (Urothelial Cell Carcinoma) – Drugs In Development, 2024 report and make more profitable business decisions. Transitional cell carcinoma (TCC), also known asurothelial cell carcinoma, is a type of cancer that primarily affects the transitional epithelial cells lining the urinary tract, including the bladder, ureters, and renal pelvis. It is the most common form of bladder cancer. TCC arises when these cells undergo malignant changes, often due to exposure to carcinogens like tobacco or...
-
Product Insights
Thyroid Cancer - Drugs In Development, 2024
Empower your strategies with our Thyroid Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Thyroid cancer is a cancer that starts in the thyroid gland. Symptoms include a lump that can be felt through the skin on the neck, difficulty swallowing, pain in neck and throat, and swollen lymph nodes in the neck. Predisposing factors include female sex, high levels of radiation exposure, and inherited genetic syndromes. Treatment includes surgery and thyroid hormone therapy. The Thyroid...
-
Product Insights
Neuroblastoma - Drugs In Development, 2024
Empower your strategies with our Neuroblastoma – Drugs In Development, 2024 report and make more profitable business decisions. Neuroblastoma is the cancer of the nerve tissues and neural crest cells of adrenal glands, neck, chest, or spinal cord, occurring predominantly in children. It usually begins in the adrenal glands before spreading to other parts of the body. The predisposing factors involved in neuroblastoma include genetic conditions. Symptoms include a lump in the abdomen or chest, weakness, bone pain, breathing problems, dark...
-
Product Insights
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) - Drugs In Development, 2024
Empower your strategies with our B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) – Drugs In Development, 2024 report and make more profitable business decisions. B-cell acute lymphocytic leukemia (B-Cell ALL), also known as B-cell acute lymphoblastic leukemia, is a type of blood cancer that originates in the bone marrow and affects B-cell lymphocytes, a type of white blood cell. In B-cell ALL, these immature B cells undergo malignant transformation, leading to the rapid production of abnormal lymphoblasts. These abnormal cells...
-
Product Insights
Gastroesophageal (GE) Junction Carcinomas - Drugs In Development, 2024
Empower your strategies with our Gastroesophageal (GE) Junction Carcinomas – Drugs In Development, 2024 report and make more profitable business decisions. Gastroesophageal (GE) junction carcinomas are malignancies occurring at the point where the esophagus meets the stomach. Typically classified as adenocarcinomas or squamous cell carcinomas, adenocarcinomas are more prevalent. Risk factors include chronic gastroesophageal reflux disease (GERD), obesity, and smoking. Symptoms often manifest in advanced stages, including difficulty swallowing, weight loss, and abdominal pain. Diagnosis involves endoscopic procedures and imaging studies....
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.